Acute limb ischemia after femoral arterial closure with a vascular sealing device: Successful endovascular treatment

Vasa - Journal of Vascular Diseases

Volumn 33, Issue 4, 2004, Pages 252-256

  Schiele, T M ^a   Rademacher, A ^a   Meissner, O ^a   Klauss, V ^a   Hoffmann, Ulrich ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Acute vascular occlusion; Collagen; Percutaneous catheter therapy; Thrombin; Vascular sealing

Indexed keywords

COLLAGEN; THROMBIN;

ADULT; ANGIOCARDIOGRAPHY; ARTERY OCCLUSION; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; DEVICE; EMBOLISM; ENDOVASCULAR SURGERY; HUMAN; LEG ARTERY; LIMB ISCHEMIA; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; SURGICAL RISK; THROMBECTOMY; VASCULAR SEALING DEVICE;

ANGIOPLASTY, BALLOON; FEMORAL ARTERY; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; POPLITEAL ARTERY; TISSUE ADHESIVES; TREATMENT OUTCOME;

EID: 9644255729     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.33.4.252     Document Type: Article

References (18)

1. Baim DS, Knopf WD, Hinohara T, et al. Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials. Am J Cardiol. 2000; 85: 864-9.
2. Dick RJ, Popma JJ, Muller DW, et al. In-hospital costs associated with new percutaneous coronary devices. Am J Cardiol. 1991; 68: 879-85.
3. Gershony G, Brock JM, Powell JS. Novel vascular sealing device for closure of percutaneous vascular access sites. Cathet Cardiovasc Diagn. 1998; 45: 82-88; discussion 90-91.
4. Goyen M, Manz S, Kroger K, et al. Interventional therapy of vascular complications caused by the hemostatic puncture closure device angio-seal. Catheter Cardiovasc Interv. 2000; 49: 142-7.
5. Hoffer EK, Bloch RD. Percutaneous arterial closure devices. J Vase Interv Radiol. 2003; 14: 865-85.
6. Kahn ZM, Kumar M, Hollander G, et al. Safety and efficacy of the Perclose suture-mediated closure device after diagnostic and interventional catheterizations in a large consecutive population. Catheter Cardiovasc Interv. 2002; 55: 8-13.
7. Koreny M, Riedmuller E, Nikfardjam M, et al. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004; 291: 350-7.
8. Kussmaul WG 3rd, Buchbinder M, Whitlow PL, et al. Rapid arterial hemostasis and decreased access site complications after cardiac catheterization and angioplasty: results of a randomized trial of a novel hemostatic device. J Am Coll Cardiol. 1995; 25: 1685-92.
9. Mooney MR, Ellis SG, Gershony G, et al. Immediate sealing of arterial puncture sites after cardiac catheterization and coronary interventions: initial U.S. feasibility trial using the Duett vascular closure device. Catheter Cardiovasc Interv. 2000; 50: 96-102.
10. Nasser TK, Mohler ER 3rd, Wilensky RL, et al. Peripheral vascular complications following coronary interventional procedures. Clin Cardiol. 1995; 18: 609-14.
11. Oweida SW, Roubin GS, Smith RB 3rd, et al. Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty. J Vasc Surg. 1990; 12: 310-5.
12. Resnic FS, Blake GJ, Ohnc-Machado L, et al. Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. Am J Cardiol. 2001; 88: 493-6.
13. Schürmann K, Janssens U, Bucker A, et al. Local lysis with alteplase for the treatment of acute embolic leg ischemia following the use of the duett closure device: preliminary results. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 2004; 176: 574-9.
14. Shammas NW, Rajendran VR, Alldredge SG, et al. Randomized comparison of Vasoseal and Angioseal closure devices in patients undergoing coronary angiography and angioplasty. Catheter Cardiovasc Interv. 2002; 55: 421-7.
15. Silber S, Tofte AJ, Kjellevand TO, et al. Final report of the European multi-center registry using the Duett vascular sealing device. Herz. 1999; 24: 620-3.
16. Skillman JJ, Kim D, Baim DS. Vascular complications of percutaneous femoral cardiac interventions. Incidence and operative repair. Arch Surg. 1988; 123: 1207-12.
17. The SEAL Trial Study Team. Assessment of the safety and efficacy of the DUETT vascular hemostasis device: final results of the safe and effective vascular hemostasis (SEAL) trial. Am Heart J. 2002; 143: 612-9.
18. Zhang Z, Mahoney EM, Gershony G, et al. Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial. Am Heart J. 2001; 142: 982-8.